权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

In-vitro analysis of HSV-1 membrane fusion mechanism

HSV-1膜融合机制的体外分析

基本信息

批准号：
10373110
负责人：
Ekaterina Heldwein
金额：
$ 20万
依托单位：
TUFTS UNIVERSITY BOSTON
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-03-17 至 2024-02-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10373110
关键词：
Address Biological Assay Blindness Cell fusion Cell membrane Cells Data Dissection Encephalitis Future Glycoproteins Goals Herpes Labialis Herpesviridae Herpesvirus 1 Human Human Herpesvirus 2 Image Immunocompromised Host In Vitro Individual Infection Investigation Kinetics Knowledge Label Life Lipid Bilayers Liquid substance Measurement Measures Mediating Membrane Membrane Fusion Membrane Lipids Methodology Microscopy Modeling Molecular Conformation Mutagenesis Nature Newborn Infant Participant Pathway interactions Process Proteins Reagent Reporter Research Role Series Side Simplexvirus System Technology Therapeutic Time Vaccines Vesicular stomatitis Indiana virus Viral Virion Virus Virus Diseases Visualization Work bone combat conformational conversion design env Gene Products follow-up genital herpes innovation novel particle protein function receptor receptor binding reconstitution tool virus envelope

项目摘要

PROJECT SUMMARY/ABSTRACT Herpes Simplex virus type 1 (HSV-1) requires four glycoproteins for cell entry and membrane fusion – gB, gD, gH, and gL – in addition to a cellular receptor. A thorough knowledge of membrane fusion mechanisms is essential for understanding how herpesviruses penetrate cells and finding ways to inhibit this process. Due to the complexity of this process, many fundamental questions endure despite decades of research. Moreover, traditional entry assays rely on downstream reporters and do not measure fusion directly. Studies of cell-cell fusion of uninfected receptor-bearing cells expressing the four essential HSV entry glycoproteins have yielded much of the current mechanistic knowledge of membrane fusion, including the prevalent regulatory cascade model. However, the cell-cell fusion system, while informative, fails to capture the proper context of virus-cell fusion. Accurate, systematic dissection of the HSV-mediated membrane fusion mechanism thus requires an experimentally tractable system that enables direct visualization and kinetic measurements of the viral fusion. The goal of this exploratory proposal is to reconstitute HSV-1 fusion in vitro and to characterize it at a single- virion level by imaging fusion of individual virions with fluid, supported lipid bilayers using total internal reflection microscopy. This approach will be used to visualize different stages in fusion, measure their kinetic parameters, identify kinetic intermediates, and correlate them with structural rearrangements in gB. In addition to HSV-1, the proposed studies will employ Vesicular Stomatitis Virus (VSV) virions lacking the native fusogen G and pseudotyped with HSV-1 entry glycoproteins gB, gD, gH, and gL (VSVDG-BHLD). The use of this simplified, “bare-bones” system will benefit this work by excluding the potential effects of the 12 other envelope proteins. In-vitro reconstitution of fusion and its characterization at a single particle level will address the lingering questions in HSV-mediated membrane fusion mechanism, with the ultimate goal of reconstructing the HSV-1-mediated fusion pathway more fully.

项目总结/摘要单纯疱疹病毒1型（HSV-1）需要四种糖蛋白用于细胞进入和膜融合- gB，gD， gH和gL -除了细胞受体之外。对膜融合机制的透彻了解是对于理解疱疹病毒如何穿透细胞和找到抑制这一过程的方法至关重要。由于由于这一过程的复杂性，尽管经过了几十年的研究，许多基本问题仍然存在。此外，委员会认为，传统的进入测定依赖于下游报道基因，并且不直接测量融合。细胞-细胞研究表达四种HSV必需的进入糖蛋白的未感染的携带受体的细胞的融合已经产生了目前许多关于膜融合的机制知识，包括普遍存在的调节级联，模型然而，细胞-细胞融合系统虽然信息丰富，但未能捕获病毒-细胞融合的适当背景。核聚变因此，对HSV介导的膜融合机制的准确、系统的解剖需要一个实验上易于处理的系统，能够直接可视化和病毒融合的动力学测量。这项探索性建议的目标是在体外重建HSV-1融合，并在单个细胞中对其进行表征。通过使用全内反射将单个病毒粒子与液体支持的脂质双层进行成像融合来确定病毒粒子水平显微镜这种方法将用于可视化聚变的不同阶段，测量它们的动力学参数，确定动力学中间体，并将它们与gB中的结构重排相关联。此外对于HSV-1，拟议的研究将使用缺乏天然融合子的水泡性口炎病毒（VSV）病毒粒子用HSV-1进入糖蛋白gB、gD、gH和gL假型化（VSVDG-BHLD）。使用这种一个简化的“基本”系统将排除其他12个包层的潜在影响，从而使这项工作受益 proteins.融合的体外重建及其在单个颗粒水平上的表征将解决 HSV介导的膜融合机制中挥之不去的问题，最终目标是重建 HSV-1介导的融合途径更充分。